Summary

The global Ultrasound Coupling Gel market is projected to grow from US$ 139 million in 2025 to US$ 187 million by 2032, at a CAGR of 4.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Ultrasound Coupling Gel is a water‑based viscous conductive medium composed of deionized water, humectants, thickeners, preservatives and pH regulators. It eliminates air gaps between ultrasound probes and human or animal skin surface during ultrasonic examination and therapy, reduces acoustic impedance difference to ensure effective transmission of ultrasonic energy. The gel features non‑irritating property, moderate viscosity and good biocompatibility; it avoids image artifacts caused by air, supports clear ultrasound imaging, and can be easily wiped off after operation. It is widely used in medical diagnostic ultrasound, physical ultrasonic therapy and veterinary ultrasonic inspection scenarios.
Key Findings
Ultrasound Coupling Gel demand is anchored by recurring consumption across diagnostic imaging, therapeutic ultrasound, obstetric examinations, and veterinary procedures
Sterile Ultrasound Coupling Gel addresses procedures with stricter infection-control requirements, while non-sterile products remain important for routine high-frequency examinations
Product differentiation increasingly centers on acoustic consistency, viscosity control, skin compatibility, packaging convenience, and microbiological quality
The competitive landscape combines specialized coupling-media manufacturers, broader medical consumables suppliers, and regional manufacturers serving institutional procurement channels
Market Trends
The Ultrasound Coupling Gel market is evolving from a relatively standardized medical consumable category toward more differentiated products designed around clinical workflow, infection prevention, patient comfort, and packaging efficiency. Healthcare providers increasingly evaluate not only basic acoustic transmission performance but also consistency during prolonged scanning, resistance to dripping or drying, ease of probe movement, residue removal, skin tolerance, and compatibility with different ultrasound procedures. Sterile product formats are receiving greater attention in examination environments where contamination control is more stringent, while single-use and procedure-oriented packaging can support standardized clinical practices and reduce handling risks. At the same time, manufacturers are refining viscosity, formulation stability, dispensing design, and packaging volumes to serve different care settings ranging from centralized imaging departments to decentralized point-of-care environments. Long-term product development is therefore likely to focus on balancing acoustic performance, microbiological safety, usability, and cost efficiency rather than relying solely on basic formulation functionality.
Market Dynamics
Drivers
Demand for Ultrasound Coupling Gel is primarily supported by the broad installed base and recurring utilization of ultrasound equipment across hospitals, imaging centers, outpatient facilities, rehabilitation settings, obstetric practices, and veterinary clinics. Unlike capital ultrasound equipment, coupling gel is a consumable product that must be replenished continuously as examination volumes increase. Expansion of ultrasound into point-of-care diagnostics, musculoskeletal assessment, rehabilitation therapy, obstetric monitoring, and veterinary diagnosis broadens the consumption base. Greater emphasis on standardized scanning quality and reliable probe-to-surface contact also supports the use of purpose-formulated coupling products rather than improvised alternatives. In markets with expanding healthcare infrastructure, increasing availability of ultrasound systems can create additional recurring demand for associated consumables.
Restraints
The relatively mature formulation technology of standard Non-sterile Ultrasound Coupling Gel can limit product differentiation and contribute to price-based competition, particularly in high-volume institutional procurement. Raw materials such as purified water, humectants, thickeners, preservatives, packaging materials, and dispensing components are generally accessible, reducing technological entry barriers for conventional products. At the same time, hospitals and distributors frequently emphasize procurement cost, packaging efficiency, and supply reliability, which can restrict manufacturers' pricing flexibility. Sterile products face additional requirements in manufacturing control, sterilization validation, packaging integrity, and quality assurance, creating higher production costs that may constrain adoption in applications where sterile conditions are not operationally necessary.
Opportunities
Future opportunities are concentrated in differentiated Ultrasound Coupling Gel formulations and application-specific packaging rather than simple expansion of conventional bulk products. Sterile formats can benefit from clinical environments with stricter infection-control protocols, while compact single-use packs can address portable ultrasound, emergency medicine, mobile care, and decentralized examination scenarios. Manufacturers can also create value through optimized viscosity profiles for different scanning techniques, improved skin compatibility, reduced residue, easier dispensing, and packaging designed for more controlled utilization. Veterinary ultrasound and physical ultrasound therapy provide additional channels beyond conventional diagnostic imaging, particularly where procedure frequency and specialized workflow requirements support recurring consumable demand.
Challenges
The principal challenge is maintaining consistent product quality while competing in a market where conventional formulations can appear highly substitutable to end users. Suppliers must control viscosity, acoustic properties, microbiological quality, formulation stability, and packaging integrity across production batches without materially increasing cost. For Sterile Ultrasound Coupling Gel, quality-system requirements and sterile packaging controls further raise operational complexity. Manufacturers also need to accommodate different purchasing models across hospitals, distributors, clinics, rehabilitation institutions, and veterinary customers. Competitive pressure from both global medical consumables companies and regional suppliers may therefore place sustained pressure on pricing, while product differentiation must remain clinically meaningful enough to influence procurement decisions.
Industry Chain Analysis
The upstream industry chain of Ultrasound Coupling Gel primarily comprises purified-water systems, humectants, rheology and thickening agents, preservatives, pH-adjustment ingredients, specialty formulation materials, and plastic packaging components such as bottles, caps, dispensers, sachets, and sterile packs. Although formulation ingredients account for an important part of product performance, value creation depends heavily on maintaining formulation consistency, microbiological control, suitable viscosity, stable acoustic transmission, and reliable packaging. Sterile products require additional process controls related to controlled manufacturing environments, sterilization or aseptic processing strategies, packaging validation, and traceability, resulting in a more demanding manufacturing chain than standard non-sterile products.
Midstream activities include formulation development, raw-material preparation, mixing and homogenization, filling, packaging, quality inspection, sterilization where required, and distribution. Downstream customers include hospitals, diagnostic imaging centers, obstetric and gynecological practices, rehabilitation and physiotherapy institutions, veterinary clinics, medical distributors, and other ultrasound users. For standard products, manufacturing scale, procurement efficiency, and distribution coverage are important sources of competitiveness. For more specialized or sterile products, formulation know-how, quality assurance, regulatory compliance, packaging design, and clinical-channel access contribute more significantly to value creation. As a consumable product, recurring procurement and stable customer supply relationships are also important components of commercial value.
Segment Insights
By product type, the Ultrasound Coupling Gel market is divided into Sterile Ultrasound Coupling Gel and Non-sterile Ultrasound Coupling Gel. Non-sterile products are suited to routine examinations where conventional infection-control procedures are sufficient and therefore benefit from broad usability, larger-volume packaging options, and cost-efficient procurement. Their competitive focus tends to center on consistent viscosity, acoustic transmission, skin compatibility, ease of cleaning, and reliable supply. Sterile Ultrasound Coupling Gel serves procedures and clinical environments requiring tighter contamination control. This segment has more demanding requirements relating to microbiological quality, packaging integrity, traceability, and single-use convenience, creating a higher technical and quality-management threshold.
From an application perspective, Clinical Diagnostic Ultrasonic Scanning represents a broad recurring demand base because coupling media are required whenever stable transducer-to-skin contact is needed. Obstetric And Gynecological Ultrasound Inspection has similarly repetitive consumption characteristics, while Physical Ultrasound Therapy Examination creates demand in rehabilitation and physiotherapy workflows. Veterinary Animal Ultrasonic Diagnosis extends the addressable market beyond human healthcare and requires products suited to diverse examination conditions. The remaining applications provide additional niche demand, with purchasing requirements varying according to procedure frequency, sterility expectations, packaging format, and institutional workflow.
Downstream Market Opportunities
Downstream opportunities for Ultrasound Coupling Gel are increasingly linked to the decentralization of ultrasound use. Clinical Diagnostic Ultrasonic Scanning remains the principal usage environment, but wider adoption of ultrasound systems across outpatient departments, emergency settings, specialized clinics, and portable examination scenarios can increase the number of consumption points. Obstetric And Gynecological Ultrasound Inspection offers stable repetitive demand driven by standardized examination workflows, while Physical Ultrasound Therapy Examination supports recurring use in rehabilitation and physiotherapy institutions. Veterinary Animal Ultrasonic Diagnosis represents another differentiated opportunity, particularly where dedicated products or packaging can improve ease of operation. Suppliers capable of aligning package size, dispensing format, sterility level, and viscosity with specific downstream procedures are better positioned to move beyond commodity procurement and address higher-value application requirements.
Regional Insights
Regional market development reflects differences in ultrasound equipment penetration, healthcare expenditure, hospital and clinic density, infection-control practices, local manufacturing capacity, and medical consumables distribution systems. Developed healthcare markets generally feature mature ultrasound utilization across diagnostic imaging, obstetrics, specialist care, and point-of-care applications, supporting demand for both conventional and more specialized Ultrasound Coupling Gel products. Procurement in these markets places greater emphasis on product consistency, compliance documentation, packaging usability, and supply reliability, while sterile formats can find broader application in procedures governed by stricter clinical protocols.
Emerging healthcare markets present opportunities through continued expansion of diagnostic infrastructure, ultrasound equipment deployment, private healthcare services, and regional medical-device manufacturing. Local producers can compete effectively in routine Non-sterile Ultrasound Coupling Gel through manufacturing cost, distribution responsiveness, and institutional relationships, while established suppliers can differentiate through quality systems, specialized formulations, and sterile offerings. Regional competition is therefore shaped by a combination of healthcare-system maturity, regulatory requirements, local production economics, and the relative importance of hospital tenders versus distributor-led sales.
Competitive Landscape Analysis
The Ultrasound Coupling Gel market is characterized by a combination of specialized gel manufacturers, diversified medical consumables companies, ultrasound-related medical technology suppliers, and regional producers. Parker Laboratories, Ultragel, Medline, HR Pharmaceuticals, National Therapy, Tele-Paper, Phyto Performance, Besmed, Bioearth Laboratories, Safersonic, DEAS, NEXT Medical Products, EF Medica, Compass Health Brands, Dynarex, Telic Group, GIMA, Trivitron Healthcare, Jianerkang Medical, Foshan Pingchuang Medical Technology, Sanji Medical, FUJIFILM, Canon Medtech Supply, and JEX participate from different positions across product specialization, medical consumables distribution, imaging-related channels, and regional manufacturing. Competitive differentiation is based less on fundamental acoustic coupling functionality and more on formulation consistency, sterility options, microbiological quality, viscosity control, packaging format, manufacturing scale, regulatory and quality-management capability, distribution reach, and institutional customer access. Companies with established medical channels can leverage broader procurement relationships, while specialized manufacturers can compete through product depth and technical formulation expertise. Regional producers are positioned to benefit from localized manufacturing and cost-sensitive procurement, making supply reliability and quality consistency important determinants of sustainable competitiveness.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Ultrasound Coupling Gel market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Parker Laboratories
Ultragel
Medline
HR Pharmaceuticals
National Therapy
Tele-Paper
Phyto Performance
Besmed
Bioearth Laboratories
Safersonic
DEAS
NEXT Medical Products
EF Medica
Compass Health Brands
Dynarex
Telic Group
GIMA
Trivitron Healthcare
Jianerkang Medical
Foshan Pingchuang Medical Technology
Sanji Medical
FUJIFILM
Canon Medtech Supply
JEX
Segment by Type
Sterile Ultrasound Coupling Gel
Non-sterile Ultrasound Coupling Gel
Segment by Application Object
Human‑Use Ultrasound Coupling Gel
Veterinary‑Use Ultrasound Coupling Gel
Segment by Viscosity
Low-Viscosity Gel: < 30,000 mPa·s
Medium-Viscosity Gel: 30,000–100,000 mPa·s
High-Viscosity Gel: > 100,000 mPa·s
Segment by Application
Clinical Diagnostic Ultrasonic Scanning
Physical Ultrasound Therapy Examination
Obstetric and Gynecological Ultrasound Inspection
Veterinary Animal Ultrasonic Diagnosis
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Ultrasound Coupling Gel study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Ultrasound Coupling Gel: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Ultrasound Coupling Gel Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Sterile Ultrasound Coupling Gel
1.2.3 Non-sterile Ultrasound Coupling Gel
1.3 Market Segmentation by Application Object
1.3.1 Global Ultrasound Coupling Gel Market Size by Application Object, 2021 vs 2025 vs 2032
1.3.2 Human‑Use Ultrasound Coupling Gel
1.3.3 Veterinary‑Use Ultrasound Coupling Gel
1.4 Market Segmentation by Viscosity
1.4.1 Global Ultrasound Coupling Gel Market Size by Viscosity, 2021 vs 2025 vs 2032
1.4.2 Low-Viscosity Gel: < 30,000 mPa·s
1.4.3 Medium-Viscosity Gel: 30,000–100,000 mPa·s
1.4.4 High-Viscosity Gel: > 100,000 mPa·s
1.5 Market Segmentation by Application
1.5.1 Global Ultrasound Coupling Gel Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Clinical Diagnostic Ultrasonic Scanning
1.5.3 Physical Ultrasound Therapy Examination
1.5.4 Obstetric and Gynecological Ultrasound Inspection
1.5.5 Veterinary Animal Ultrasonic Diagnosis
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Ultrasound Coupling Gel Revenue Estimates and Forecasts (2021-2032)
2.2 Global Ultrasound Coupling Gel Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Ultrasound Coupling Gel Sales Estimates and Forecasts (2021-2032)
2.4 Global Ultrasound Coupling Gel Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Ultrasound Coupling Gel Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Ultrasound Coupling Gel Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Sterile Ultrasound Coupling Gel: Market Share by Key Manufacturers
3.5.2 Non-sterile Ultrasound Coupling Gel: Market Share by Key Manufacturers
3.6 Global Ultrasound Coupling Gel Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Ultrasound Coupling Gel Sales Performance by Type
4.1.1 Global Ultrasound Coupling Gel Sales Volume by Type (2021-2032)
4.1.2 Global Ultrasound Coupling Gel Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Ultrasound Coupling Gel Sales Performance by Application Object
4.2.1 Global Ultrasound Coupling Gel Sales Volume by Application Object (2021-2032)
4.2.2 Global Ultrasound Coupling Gel Revenue by Application Object (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Application Object (2021-2032)
4.3 Global Ultrasound Coupling Gel Sales Performance by Viscosity
4.3.1 Global Ultrasound Coupling Gel Sales Volume by Viscosity (2021-2032)
4.3.2 Global Ultrasound Coupling Gel Revenue by Viscosity (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Viscosity (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Ultrasound Coupling Gel Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Ultrasound Coupling Gel Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Ultrasound Coupling Gel Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Ultrasound Coupling Gel Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Ultrasound Coupling Gel Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Ultrasound Coupling Gel Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Ultrasound Coupling Gel Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Ultrasound Coupling Gel Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Ultrasound Coupling Gel Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Ultrasound Coupling Gel Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Ultrasound Coupling Gel Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Ultrasound Coupling Gel Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Parker Laboratories
11.1.1 Parker Laboratories Corporation Information
11.1.2 Parker Laboratories Business Overview
11.1.3 Parker Laboratories Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.1.4 Parker Laboratories Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Parker Laboratories Ultrasound Coupling Gel Sales by Product in 2025
11.1.6 Parker Laboratories Ultrasound Coupling Gel Sales by Application in 2025
11.1.7 Parker Laboratories Ultrasound Coupling Gel Sales by Geographic Area in 2025
11.1.8 Parker Laboratories Ultrasound Coupling Gel SWOT Analysis
11.1.9 Parker Laboratories Recent Developments
11.2 Ultragel
11.2.1 Ultragel Corporation Information
11.2.2 Ultragel Business Overview
11.2.3 Ultragel Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.2.4 Ultragel Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Ultragel Ultrasound Coupling Gel Sales by Product in 2025
11.2.6 Ultragel Ultrasound Coupling Gel Sales by Application in 2025
11.2.7 Ultragel Ultrasound Coupling Gel Sales by Geographic Area in 2025
11.2.8 Ultragel Ultrasound Coupling Gel SWOT Analysis
11.2.9 Ultragel Recent Developments
11.3 Medline
11.3.1 Medline Corporation Information
11.3.2 Medline Business Overview
11.3.3 Medline Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.3.4 Medline Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Medline Ultrasound Coupling Gel Sales by Product in 2025
11.3.6 Medline Ultrasound Coupling Gel Sales by Application in 2025
11.3.7 Medline Ultrasound Coupling Gel Sales by Geographic Area in 2025
11.3.8 Medline Ultrasound Coupling Gel SWOT Analysis
11.3.9 Medline Recent Developments
11.4 HR Pharmaceuticals
11.4.1 HR Pharmaceuticals Corporation Information
11.4.2 HR Pharmaceuticals Business Overview
11.4.3 HR Pharmaceuticals Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.4.4 HR Pharmaceuticals Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 HR Pharmaceuticals Ultrasound Coupling Gel Sales by Product in 2025
11.4.6 HR Pharmaceuticals Ultrasound Coupling Gel Sales by Application in 2025
11.4.7 HR Pharmaceuticals Ultrasound Coupling Gel Sales by Geographic Area in 2025
11.4.8 HR Pharmaceuticals Ultrasound Coupling Gel SWOT Analysis
11.4.9 HR Pharmaceuticals Recent Developments
11.5 National Therapy
11.5.1 National Therapy Corporation Information
11.5.2 National Therapy Business Overview
11.5.3 National Therapy Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.5.4 National Therapy Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 National Therapy Ultrasound Coupling Gel Sales by Product in 2025
11.5.6 National Therapy Ultrasound Coupling Gel Sales by Application in 2025
11.5.7 National Therapy Ultrasound Coupling Gel Sales by Geographic Area in 2025
11.5.8 National Therapy Ultrasound Coupling Gel SWOT Analysis
11.5.9 National Therapy Recent Developments
11.6 Tele-Paper
11.6.1 Tele-Paper Corporation Information
11.6.2 Tele-Paper Business Overview
11.6.3 Tele-Paper Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.6.4 Tele-Paper Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Tele-Paper Recent Developments
11.7 Phyto Performance
11.7.1 Phyto Performance Corporation Information
11.7.2 Phyto Performance Business Overview
11.7.3 Phyto Performance Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.7.4 Phyto Performance Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Phyto Performance Recent Developments
11.8 Besmed
11.8.1 Besmed Corporation Information
11.8.2 Besmed Business Overview
11.8.3 Besmed Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.8.4 Besmed Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Besmed Recent Developments
11.9 Bioearth Laboratories
11.9.1 Bioearth Laboratories Corporation Information
11.9.2 Bioearth Laboratories Business Overview
11.9.3 Bioearth Laboratories Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.9.4 Bioearth Laboratories Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Bioearth Laboratories Recent Developments
11.10 Safersonic
11.10.1 Safersonic Corporation Information
11.10.2 Safersonic Business Overview
11.10.3 Safersonic Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.10.4 Safersonic Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Safersonic Recent Developments
11.11 DEAS
11.11.1 DEAS Corporation Information
11.11.2 DEAS Business Overview
11.11.3 DEAS Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.11.4 DEAS Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 DEAS Recent Developments
11.12 NEXT Medical Products
11.12.1 NEXT Medical Products Corporation Information
11.12.2 NEXT Medical Products Business Overview
11.12.3 NEXT Medical Products Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.12.4 NEXT Medical Products Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 NEXT Medical Products Recent Developments
11.13 EF Medica
11.13.1 EF Medica Corporation Information
11.13.2 EF Medica Business Overview
11.13.3 EF Medica Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.13.4 EF Medica Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 EF Medica Recent Developments
11.14 Compass Health Brands
11.14.1 Compass Health Brands Corporation Information
11.14.2 Compass Health Brands Business Overview
11.14.3 Compass Health Brands Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.14.4 Compass Health Brands Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Compass Health Brands Recent Developments
11.15 Dynarex
11.15.1 Dynarex Corporation Information
11.15.2 Dynarex Business Overview
11.15.3 Dynarex Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.15.4 Dynarex Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Dynarex Recent Developments
11.16 Telic Group
11.16.1 Telic Group Corporation Information
11.16.2 Telic Group Business Overview
11.16.3 Telic Group Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.16.4 Telic Group Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Telic Group Recent Developments
11.17 GIMA
11.17.1 GIMA Corporation Information
11.17.2 GIMA Business Overview
11.17.3 GIMA Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.17.4 GIMA Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 GIMA Recent Developments
11.18 Trivitron Healthcare
11.18.1 Trivitron Healthcare Corporation Information
11.18.2 Trivitron Healthcare Business Overview
11.18.3 Trivitron Healthcare Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.18.4 Trivitron Healthcare Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Trivitron Healthcare Recent Developments
11.19 Jianerkang Medical
11.19.1 Jianerkang Medical Corporation Information
11.19.2 Jianerkang Medical Business Overview
11.19.3 Jianerkang Medical Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.19.4 Jianerkang Medical Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Jianerkang Medical Recent Developments
11.20 Foshan Pingchuang Medical Technology
11.20.1 Foshan Pingchuang Medical Technology Corporation Information
11.20.2 Foshan Pingchuang Medical Technology Business Overview
11.20.3 Foshan Pingchuang Medical Technology Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.20.4 Foshan Pingchuang Medical Technology Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Foshan Pingchuang Medical Technology Recent Developments
11.21 Sanji Medical
11.21.1 Sanji Medical Corporation Information
11.21.2 Sanji Medical Business Overview
11.21.3 Sanji Medical Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.21.4 Sanji Medical Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Sanji Medical Recent Developments
11.22 FUJIFILM
11.22.1 FUJIFILM Corporation Information
11.22.2 FUJIFILM Business Overview
11.22.3 FUJIFILM Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.22.4 FUJIFILM Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 FUJIFILM Recent Developments
11.23 Canon Medtech Supply
11.23.1 Canon Medtech Supply Corporation Information
11.23.2 Canon Medtech Supply Business Overview
11.23.3 Canon Medtech Supply Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.23.4 Canon Medtech Supply Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Canon Medtech Supply Recent Developments
11.24 JEX
11.24.1 JEX Corporation Information
11.24.2 JEX Business Overview
11.24.3 JEX Ultrasound Coupling Gel Product Models, Descriptions and Specifications
11.24.4 JEX Ultrasound Coupling Gel Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 JEX Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Ultrasound Coupling Gel Industry Chain
12.2 Ultrasound Coupling Gel Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Ultrasound Coupling Gel Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Ultrasound Coupling Gel Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Ultrasound Coupling Gel Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Ultrasound Coupling Gel Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Ultrasound Coupling Gel Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Ultrasound Coupling Gel Market Size Growth Rate by Application Object, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Ultrasound Coupling Gel Market Size Growth Rate by Viscosity, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Ultrasound Coupling Gel Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Ultrasound Coupling Gel Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Ultrasound Coupling Gel Revenue by Region (US$ Million), 2021-2026
Table 7. Global Ultrasound Coupling Gel Revenue by Region (US$ Million), 2027-2032
Table 8. Global Ultrasound Coupling Gel Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Kiloliters)
Table 9. Global Ultrasound Coupling Gel Sales by Region (Kiloliters), 2021-2026
Table 10. Global Ultrasound Coupling Gel Sales by Region (Kiloliters), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Ultrasound Coupling Gel Sales by Manufacturers (Kiloliters), 2021-2026
Table 13. Global Ultrasound Coupling Gel Sales Share by Manufacturers (2021-2026)
Table 14. Global Ultrasound Coupling Gel Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Ultrasound Coupling Gel Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Ultrasound Coupling Gel Revenue, 2025
Table 18. Global Ultrasound Coupling Gel Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Ultrasound Coupling Gel Average Selling Price (ASP) by Manufacturers (US$/L), 2021-2026
Table 20. Key Manufacturers Ultrasound Coupling Gel Manufacturing Base and Headquarters
Table 21. Global Ultrasound Coupling Gel Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Ultrasound Coupling Gel Sales Volume by Type (Kiloliters), 2021-2026
Table 25. Global Ultrasound Coupling Gel Sales Volume by Type (Kiloliters), 2027-2032
Table 26. Global Ultrasound Coupling Gel Revenue by Type (US$ Million), 2021-2026
Table 27. Global Ultrasound Coupling Gel Revenue by Type (US$ Million), 2027-2032
Table 28. Global Ultrasound Coupling Gel Sales Volume by Application Object (Kiloliters), 2021-2026
Table 29. Global Ultrasound Coupling Gel Sales Volume by Application Object (Kiloliters), 2027-2032
Table 30. Global Ultrasound Coupling Gel Revenue by Application Object (US$ Million), 2021-2026
Table 31. Global Ultrasound Coupling Gel Revenue by Application Object (US$ Million), 2027-2032
Table 32. Global Ultrasound Coupling Gel Sales Volume by Viscosity (Kiloliters), 2021-2026
Table 33. Global Ultrasound Coupling Gel Sales Volume by Viscosity (Kiloliters), 2027-2032
Table 34. Global Ultrasound Coupling Gel Revenue by Viscosity (US$ Million), 2021-2026
Table 35. Global Ultrasound Coupling Gel Revenue by Viscosity (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Ultrasound Coupling Gel Sales by Application (Kiloliters), 2021-2026
Table 38. Global Ultrasound Coupling Gel Sales by Application (Kiloliters), 2027-2032
Table 39. Ultrasound Coupling Gel High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Ultrasound Coupling Gel Revenue by Application (US$ Million), 2021-2026
Table 41. Global Ultrasound Coupling Gel Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Ultrasound Coupling Gel Growth Accelerators and Market Barriers
Table 45. North America Ultrasound Coupling Gel Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Ultrasound Coupling Gel Sales (Kiloliters) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Ultrasound Coupling Gel Growth Accelerators and Market Barriers
Table 48. Europe Ultrasound Coupling Gel Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Ultrasound Coupling Gel Sales (Kiloliters) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Ultrasound Coupling Gel Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Ultrasound Coupling Gel Sales (Kiloliters) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Ultrasound Coupling Gel Growth Accelerators and Market Barriers
Table 53. Southeast Asia Ultrasound Coupling Gel Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Ultrasound Coupling Gel Investment Opportunities and Key Challenges
Table 55. Central and South America Ultrasound Coupling Gel Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Ultrasound Coupling Gel Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Ultrasound Coupling Gel Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Parker Laboratories Corporation Information
Table 59. Parker Laboratories Description and Major Businesses
Table 60. Parker Laboratories Product Models, Descriptions and Specifications
Table 61. Parker Laboratories Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 62. Parker Laboratories Sales Value Proportion by Product in 2025
Table 63. Parker Laboratories Sales Value Proportion by Application in 2025
Table 64. Parker Laboratories Sales Value Proportion by Geographic Area in 2025
Table 65. Parker Laboratories Ultrasound Coupling Gel SWOT Analysis
Table 66. Parker Laboratories Recent Developments
Table 67. Ultragel Corporation Information
Table 68. Ultragel Description and Major Businesses
Table 69. Ultragel Product Models, Descriptions and Specifications
Table 70. Ultragel Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 71. Ultragel Sales Value Proportion by Product in 2025
Table 72. Ultragel Sales Value Proportion by Application in 2025
Table 73. Ultragel Sales Value Proportion by Geographic Area in 2025
Table 74. Ultragel Ultrasound Coupling Gel SWOT Analysis
Table 75. Ultragel Recent Developments
Table 76. Medline Corporation Information
Table 77. Medline Description and Major Businesses
Table 78. Medline Product Models, Descriptions and Specifications
Table 79. Medline Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 80. Medline Sales Value Proportion by Product in 2025
Table 81. Medline Sales Value Proportion by Application in 2025
Table 82. Medline Sales Value Proportion by Geographic Area in 2025
Table 83. Medline Ultrasound Coupling Gel SWOT Analysis
Table 84. Medline Recent Developments
Table 85. HR Pharmaceuticals Corporation Information
Table 86. HR Pharmaceuticals Description and Major Businesses
Table 87. HR Pharmaceuticals Product Models, Descriptions and Specifications
Table 88. HR Pharmaceuticals Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 89. HR Pharmaceuticals Sales Value Proportion by Product in 2025
Table 90. HR Pharmaceuticals Sales Value Proportion by Application in 2025
Table 91. HR Pharmaceuticals Sales Value Proportion by Geographic Area in 2025
Table 92. HR Pharmaceuticals Ultrasound Coupling Gel SWOT Analysis
Table 93. HR Pharmaceuticals Recent Developments
Table 94. National Therapy Corporation Information
Table 95. National Therapy Description and Major Businesses
Table 96. National Therapy Product Models, Descriptions and Specifications
Table 97. National Therapy Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 98. National Therapy Sales Value Proportion by Product in 2025
Table 99. National Therapy Sales Value Proportion by Application in 2025
Table 100. National Therapy Sales Value Proportion by Geographic Area in 2025
Table 101. National Therapy Ultrasound Coupling Gel SWOT Analysis
Table 102. National Therapy Recent Developments
Table 103. Tele-Paper Corporation Information
Table 104. Tele-Paper Description and Major Businesses
Table 105. Tele-Paper Product Models, Descriptions and Specifications
Table 106. Tele-Paper Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 107. Tele-Paper Recent Developments
Table 108. Phyto Performance Corporation Information
Table 109. Phyto Performance Description and Major Businesses
Table 110. Phyto Performance Product Models, Descriptions and Specifications
Table 111. Phyto Performance Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 112. Phyto Performance Recent Developments
Table 113. Besmed Corporation Information
Table 114. Besmed Description and Major Businesses
Table 115. Besmed Product Models, Descriptions and Specifications
Table 116. Besmed Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 117. Besmed Recent Developments
Table 118. Bioearth Laboratories Corporation Information
Table 119. Bioearth Laboratories Description and Major Businesses
Table 120. Bioearth Laboratories Product Models, Descriptions and Specifications
Table 121. Bioearth Laboratories Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 122. Bioearth Laboratories Recent Developments
Table 123. Safersonic Corporation Information
Table 124. Safersonic Description and Major Businesses
Table 125. Safersonic Product Models, Descriptions and Specifications
Table 126. Safersonic Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 127. Safersonic Recent Developments
Table 128. DEAS Corporation Information
Table 129. DEAS Description and Major Businesses
Table 130. DEAS Product Models, Descriptions and Specifications
Table 131. DEAS Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 132. DEAS Recent Developments
Table 133. NEXT Medical Products Corporation Information
Table 134. NEXT Medical Products Description and Major Businesses
Table 135. NEXT Medical Products Product Models, Descriptions and Specifications
Table 136. NEXT Medical Products Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 137. NEXT Medical Products Recent Developments
Table 138. EF Medica Corporation Information
Table 139. EF Medica Description and Major Businesses
Table 140. EF Medica Product Models, Descriptions and Specifications
Table 141. EF Medica Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 142. EF Medica Recent Developments
Table 143. Compass Health Brands Corporation Information
Table 144. Compass Health Brands Description and Major Businesses
Table 145. Compass Health Brands Product Models, Descriptions and Specifications
Table 146. Compass Health Brands Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 147. Compass Health Brands Recent Developments
Table 148. Dynarex Corporation Information
Table 149. Dynarex Description and Major Businesses
Table 150. Dynarex Product Models, Descriptions and Specifications
Table 151. Dynarex Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 152. Dynarex Recent Developments
Table 153. Telic Group Corporation Information
Table 154. Telic Group Description and Major Businesses
Table 155. Telic Group Product Models, Descriptions and Specifications
Table 156. Telic Group Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 157. Telic Group Recent Developments
Table 158. GIMA Corporation Information
Table 159. GIMA Description and Major Businesses
Table 160. GIMA Product Models, Descriptions and Specifications
Table 161. GIMA Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 162. GIMA Recent Developments
Table 163. Trivitron Healthcare Corporation Information
Table 164. Trivitron Healthcare Description and Major Businesses
Table 165. Trivitron Healthcare Product Models, Descriptions and Specifications
Table 166. Trivitron Healthcare Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 167. Trivitron Healthcare Recent Developments
Table 168. Jianerkang Medical Corporation Information
Table 169. Jianerkang Medical Description and Major Businesses
Table 170. Jianerkang Medical Product Models, Descriptions and Specifications
Table 171. Jianerkang Medical Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 172. Jianerkang Medical Recent Developments
Table 173. Foshan Pingchuang Medical Technology Corporation Information
Table 174. Foshan Pingchuang Medical Technology Description and Major Businesses
Table 175. Foshan Pingchuang Medical Technology Product Models, Descriptions and Specifications
Table 176. Foshan Pingchuang Medical Technology Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 177. Foshan Pingchuang Medical Technology Recent Developments
Table 178. Sanji Medical Corporation Information
Table 179. Sanji Medical Description and Major Businesses
Table 180. Sanji Medical Product Models, Descriptions and Specifications
Table 181. Sanji Medical Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 182. Sanji Medical Recent Developments
Table 183. FUJIFILM Corporation Information
Table 184. FUJIFILM Description and Major Businesses
Table 185. FUJIFILM Product Models, Descriptions and Specifications
Table 186. FUJIFILM Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 187. FUJIFILM Recent Developments
Table 188. Canon Medtech Supply Corporation Information
Table 189. Canon Medtech Supply Description and Major Businesses
Table 190. Canon Medtech Supply Product Models, Descriptions and Specifications
Table 191. Canon Medtech Supply Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 192. Canon Medtech Supply Recent Developments
Table 193. JEX Corporation Information
Table 194. JEX Description and Major Businesses
Table 195. JEX Product Models, Descriptions and Specifications
Table 196. JEX Sales (Kiloliters), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026)
Table 197. JEX Recent Developments
Table 198. Key Raw Materials Distribution
Table 199. Raw Materials Key Suppliers
Table 200. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 201. Milestones in Production Technology Evolution
Table 202. Distributors List
Table 203. Market Trends and Market Evolution
Table 204. Market Drivers and Opportunities
Table 205. Market Challenges, Risks, and Restraints
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources


List of Figures
Figure 1. Ultrasound Coupling Gel Product Picture
Figure 2. Global Ultrasound Coupling Gel Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Sterile Ultrasound Coupling Gel Product Picture
Figure 4. Non-sterile Ultrasound Coupling Gel Product Picture
Figure 5. Global Ultrasound Coupling Gel Market Size Growth Rate by Application Object, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Human‑Use Ultrasound Coupling Gel Product Picture
Figure 7. Veterinary‑Use Ultrasound Coupling Gel Product Picture
Figure 8. Global Ultrasound Coupling Gel Market Size Growth Rate by Viscosity, 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Low-Viscosity Gel: < 30,000 mPa·s Product Picture
Figure 10. Medium-Viscosity Gel: 30,000–100,000 mPa·s Product Picture
Figure 11. High-Viscosity Gel: > 100,000 mPa·s Product Picture
Figure 12. Global Ultrasound Coupling Gel Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Clinical Diagnostic Ultrasonic Scanning
Figure 14. Physical Ultrasound Therapy Examination
Figure 15. Obstetric and Gynecological Ultrasound Inspection
Figure 16. Veterinary Animal Ultrasonic Diagnosis
Figure 17. Others
Figure 18. Ultrasound Coupling Gel Report Years Considered
Figure 19. Global Ultrasound Coupling Gel Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 21. Global Ultrasound Coupling Gel Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 22. Global Ultrasound Coupling Gel Revenue-Based Market Share by Region (2021-2032)
Figure 23. Global Ultrasound Coupling Gel Sales (Kiloliters), 2021-2032
Figure 24. Global Ultrasound Coupling Gel Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (Kiloliters)
Figure 25. Global Ultrasound Coupling Gel Sales Market Share by Region (2021-2032)
Figure 26. Top 5 and Top 10 Manufacturers Ultrasound Coupling Gel Sales Volume Market Share in 2025
Figure 27. Global Ultrasound Coupling Gel Revenue-Based Market Share Ranking (2025)
Figure 28. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 29. Sterile Ultrasound Coupling Gel Revenue-Based Market Share by Manufacturer in 2025
Figure 30. Non-sterile Ultrasound Coupling Gel Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Global Ultrasound Coupling Gel Sales Volume-Based Market Share by Type (2021-2032)
Figure 32. Global Ultrasound Coupling Gel Revenue-Based Market Share by Type (2021-2032)
Figure 33. Global Ultrasound Coupling Gel ASP by Type (US$/L), 2021-2032
Figure 34. Global Ultrasound Coupling Gel Sales Volume-Based Market Share by Application Object (2021-2032)
Figure 35. Global Ultrasound Coupling Gel Revenue-Based Market Share by Application Object (2021-2032)
Figure 36. Global Ultrasound Coupling Gel ASP by Application Object (US$/L), 2021-2032
Figure 37. Global Ultrasound Coupling Gel Sales Volume-Based Market Share by Viscosity (2021-2032)
Figure 38. Global Ultrasound Coupling Gel Revenue-Based Market Share by Viscosity (2021-2032)
Figure 39. Global Ultrasound Coupling Gel ASP by Viscosity (US$/L), 2021-2032
Figure 40. Global Ultrasound Coupling Gel Sales Market Share by Application (2021-2032)
Figure 41. Global Ultrasound Coupling Gel Revenue-Based Market Share by Application (2021-2032)
Figure 42. Global Ultrasound Coupling Gel ASP by Application (US$/L), 2021-2032
Figure 43. North America Ultrasound Coupling Gel Sales YoY (Kiloliters), 2021-2032
Figure 44. North America Ultrasound Coupling Gel Revenue YoY (US$ Million), 2021-2032
Figure 45. North America Top 5 Manufacturers Ultrasound Coupling Gel Sales Revenue (US$ Million) in 2025
Figure 46. North America Ultrasound Coupling Gel Sales Volume (Kiloliters) by Application (2021-2032)
Figure 47. North America Ultrasound Coupling Gel Sales Revenue (US$ Million) by Application (2021-2032)
Figure 48. US Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 49. Canada Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 50. Mexico Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 51. Europe Ultrasound Coupling Gel Sales YoY (Kiloliters), 2021-2032
Figure 52. Europe Ultrasound Coupling Gel Revenue YoY (US$ Million), 2021-2032
Figure 53. Europe Top 5 Manufacturers Ultrasound Coupling Gel Sales Revenue (US$ Million) in 2025
Figure 54. Europe Ultrasound Coupling Gel Sales Volume (Kiloliters) by Application (2021-2032)
Figure 55. Europe Ultrasound Coupling Gel Sales Revenue (US$ Million) by Application (2021-2032)
Figure 56. Germany Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 57. France Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 58. U.K. Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 59. Italy Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 60. Russia Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 61. Asia-Pacific Ultrasound Coupling Gel Sales YoY (Kiloliters), 2021-2032
Figure 62. Asia-Pacific Ultrasound Coupling Gel Revenue YoY (US$ Million), 2021-2032
Figure 63. Asia-Pacific Top 8 Manufacturers Ultrasound Coupling Gel Sales Revenue (US$ Million) in 2025
Figure 64. Asia-Pacific Ultrasound Coupling Gel Sales Volume (Kiloliters) by Application (2021-2032)
Figure 65. Asia-Pacific Ultrasound Coupling Gel Sales Revenue (US$ Million) by Application (2021-2032)
Figure 66. Indonesia Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 67. Japan Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 68. South Korea Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 69. China Taiwan Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 70. India Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 71. Central and South America Ultrasound Coupling Gel Sales YoY (Kiloliters), 2021-2032
Figure 72. Central and South America Ultrasound Coupling Gel Revenue YoY (US$ Million), 2021-2032
Figure 73. Central and South America Top 5 Manufacturers Ultrasound Coupling Gel Sales Revenue (US$ Million) in 2025
Figure 74. Central and South America Ultrasound Coupling Gel Sales Volume (Kiloliters) by Application (2021-2032)
Figure 75. Central and South America Ultrasound Coupling Gel Sales Revenue (US$ Million) by Application (2021-2032)
Figure 76. Brazil Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 77. Argentina Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 78. Middle East, and Africa Ultrasound Coupling Gel Sales YoY (Kiloliters), 2021-2032
Figure 79. Middle East and Africa Ultrasound Coupling Gel Revenue YoY (US$ Million), 2021-2032
Figure 80. Middle East and Africa Top 5 Manufacturers Ultrasound Coupling Gel Sales Revenue (US$ Million) in 2025
Figure 81. Middle East and Africa Ultrasound Coupling Gel Sales Volume (Kiloliters) by Application (2021-2032)
Figure 82. Middle East and Africa Ultrasound Coupling Gel Sales Revenue (US$ Million) by Application (2021-2032)
Figure 83. GCC Countries Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 84. Turkey Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 85. Egypt Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 86. South Africa Ultrasound Coupling Gel Revenue (US$ Million), 2021-2032
Figure 87. Ultrasound Coupling Gel Industry Chain Mapping
Figure 88. Regional Ultrasound Coupling Gel Manufacturing Base Distribution (%)
Figure 89. Global Ultrasound Coupling Gel Production Market Share by Region (2021-2032)
Figure 90. Ultrasound Coupling Gel Production Process
Figure 91. Regional Ultrasound Coupling Gel Production Cost Structure
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed